Ambitious Bio founder and CEO Lizzy Hudson explains how the company collects donated human tissue and profiles samples to build a molecular reference for research. She focuses on proteomics, sourcing and analysis, and how customers use the resulting data. The judges ask how the resource compares with other data sources and what specimen costs mean for its model. Ambitious Bio received the contest's Audience Favorite award.
More from the studio
TechCrunch Disrupt 2026 · Lumai
Power is a practical limit on scaling AI. Lumai’s Xianxin Guo explains how the company approaches that problem with optical computing: using photons and interference to perform AI calculations. In his conversation with Dmytro Spodarets for Data Phoenix Open Mic at TechCrunch Disrupt 2026, he also discusses how Lumai’s hardware is designed to work alongside GPUs and support PyTorch-based models. Lumai is featured in Startups to Watch, the TechCrunch Disrupt 2026 series in the Data Phoenix Open Mic collection.
4:22Open MicTechCrunch Disrupt 2026 · ViVeSec Box
At TechCrunch Disrupt 2026, Deepali Gosain discusses ViVeSec Box, an NVIDIA-based on-premises AI appliance for companies working with sensitive business data. She describes a chatbot that works with local data, pre-built agents, options to add agents for business processes, and automations. The conversation also covers the built-in inference model and the closed-box approach behind the product, followed by what the team wants to learn about other solutions and market needs. ViVeSec Box is featured in Startups to Watch, the TechCrunch Disrupt 2026 series in the Data Phoenix Open Mic collection.
TechCrunch Disrupt 2026 · AIEEV
AIEEV co-founder Hyeonkyeong (Karen) Kim explains the approach behind Air Cloud: connecting edge GPU devices for AI inference, supporting container-based deployment and autoscaling, and addressing hardware and network security. Recorded at TechCrunch Disrupt 2026.